Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Carvedilol on Reducing Trastuzumab Cardiac Complications
IRCT20190628044046N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of carvedilol in Cardiomyopathies, sponsored by Tehran University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
carvedilol
03
Conditions
Cardiomyopathies
Beyond the preview
Go deeper on IRCT20190628044046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190628044046N1.